Difficulty: Medium
Average Score: 90%
Practice
Hyperprolactinemia is caused by blockade of dopamine in:
Correct answer
B
Rationale
In the context of Advanced Pharmacology Across the Lifespan, understanding the mechanism of hyperprolactinemia is crucial. The correct answer is B) The pituitary. Hyperprolactinemia is primarily caused by the blockade of dopamine D2 receptors in the pituitary gland. Dopamine normally inhibits prolactin secretion, so when its action is blocked, there is increased release of prolactin, leading to hyperprolactinemia.
Option A) The chemoreceptor trigger zone of the medulla is incorrect because dopamine blockade in this area would not directly lead to hyperprolactinemia. The chemoreceptor trigger zone is primarily involved in the regulation of nausea and vomiting.
Option C) The extrapyramidal system is incorrect as dopamine blockade in this system is associated with movement disorders like Parkinson's disease, not hyperprolactinemia.
Option D) The mesolimbic and mesofrontal systems are incorrect because dopamine blockade in these areas is associated with the positive symptoms of schizophrenia, not hyperprolactinemia.
Understanding the specific neuroendocrine pathways involved in hyperprolactinemia is essential for healthcare professionals managing patients with this condition, especially when considering pharmacological interventions that may impact dopamine receptors in the pituitary gland.
Option A) The chemoreceptor trigger zone of the medulla is incorrect because dopamine blockade in this area would not directly lead to hyperprolactinemia. The chemoreceptor trigger zone is primarily involved in the regulation of nausea and vomiting.
Option C) The extrapyramidal system is incorrect as dopamine blockade in this system is associated with movement disorders like Parkinson's disease, not hyperprolactinemia.
Option D) The mesolimbic and mesofrontal systems are incorrect because dopamine blockade in these areas is associated with the positive symptoms of schizophrenia, not hyperprolactinemia.
Understanding the specific neuroendocrine pathways involved in hyperprolactinemia is essential for healthcare professionals managing patients with this condition, especially when considering pharmacological interventions that may impact dopamine receptors in the pituitary gland.